N/a
-Diffusion Pharmaceuticals Presents Data Suggesting Optimized TSC Dosing Regimen Increases Survival in Newly Diagnosed Inoperable Glioblastoma Patients
-$19m ATM S-1 on October
-November 13th prospectus for 11.428m common shares at $0.35
-Should have 16,121,862 shares outstanding after prospectus complete
-Daily chart: huge downtrend with lots of wicks, piggy
-Recent support at 0.54
-0.56 resistance broke and turned support
First Test of 0.56 level
Had fantasy orders from 0.56 to 0.55 (thinking it would leak below like it did PM) but only got hit on my first order at 0.56, the move was done after that, small win on this trade.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2019-12-11 13:48:09 | DFFN | buy | $0.5624 | long |
2019-12-11 13:49:14 | DFFN | sell | $0.5747 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!